HRP960223B1 - Pyrrollidinyl methyl indole salt - Google Patents

Pyrrollidinyl methyl indole salt

Info

Publication number
HRP960223B1
HRP960223B1 HR960223A HRP960223A HRP960223B1 HR P960223 B1 HRP960223 B1 HR P960223B1 HR 960223 A HR960223 A HR 960223A HR P960223 A HRP960223 A HR P960223A HR P960223 B1 HRP960223 B1 HR P960223B1
Authority
HR
Croatia
Prior art keywords
pyrrollidinyl
methyl indole
indole salt
salt
methyl
Prior art date
Application number
HR960223A
Other languages
English (en)
Inventor
James Wythes Martin
Original Assignee
Pfizer Res And Dev Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res And Dev Company filed Critical Pfizer Res And Dev Company
Publication of HRP960223A2 publication Critical patent/HRP960223A2/hr
Publication of HRP960223B1 publication Critical patent/HRP960223B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR960223A 1995-05-20 1996-05-16 Pyrrollidinyl methyl indole salt HRP960223B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9510223.2A GB9510223D0 (en) 1995-05-20 1995-05-20 Therapeutic agent

Publications (2)

Publication Number Publication Date
HRP960223A2 HRP960223A2 (en) 1997-10-31
HRP960223B1 true HRP960223B1 (en) 2000-12-31

Family

ID=10774766

Family Applications (1)

Application Number Title Priority Date Filing Date
HR960223A HRP960223B1 (en) 1995-05-20 1996-05-16 Pyrrollidinyl methyl indole salt

Country Status (42)

Country Link
US (1) US5994387A (no)
EP (1) EP0827503B1 (no)
JP (1) JP3233940B2 (no)
KR (1) KR100295255B1 (no)
CN (1) CN1063175C (no)
AP (1) AP738A (no)
AR (1) AR003949A1 (no)
AT (1) ATE194986T1 (no)
AU (1) AU701154B2 (no)
BG (1) BG63046B1 (no)
BR (1) BR9610858A (no)
CA (1) CA2219631C (no)
CO (1) CO5040221A1 (no)
CZ (1) CZ287939B6 (no)
DE (1) DE69609504T2 (no)
DK (1) DK0827503T3 (no)
DZ (1) DZ2034A1 (no)
ES (1) ES2148753T3 (no)
GB (1) GB9510223D0 (no)
GR (1) GR3034290T3 (no)
HK (1) HK1017884A1 (no)
HR (1) HRP960223B1 (no)
HU (1) HU217657B (no)
IL (1) IL118239A (no)
IS (1) IS1908B (no)
LV (1) LV11992B (no)
MA (1) MA23876A1 (no)
MX (1) MX9708966A (no)
MY (1) MY132066A (no)
NO (1) NO312068B1 (no)
NZ (1) NZ306448A (no)
OA (1) OA10747A (no)
PL (1) PL183142B1 (no)
PT (1) PT827503E (no)
RU (1) RU2161618C2 (no)
SK (1) SK281782B6 (no)
TN (1) TNSN96074A1 (no)
TR (1) TR199701397T1 (no)
UA (1) UA44320C2 (no)
WO (1) WO1996036632A1 (no)
YU (1) YU29496A (no)
ZA (1) ZA963938B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
US20100266638A1 (en) * 2004-02-26 2010-10-21 Allergan, Inc. Headache treatment method
EP2875020B1 (en) * 2012-07-19 2017-09-06 Boehringer Ingelheim International GmbH Process for the preparation of a fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy- chinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3906406C1 (no) * 1989-03-01 1990-10-25 Goedecke Ag, 1000 Berlin, De
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
BR9106978A (pt) * 1990-10-15 1993-09-28 Pfizer Derivados de indol
AP486A (en) * 1993-04-27 1996-04-16 Pfizer Indole derivatives.

Also Published As

Publication number Publication date
KR100295255B1 (ko) 2001-08-07
AU701154B2 (en) 1999-01-21
AP9600801A0 (en) 1996-04-30
ATE194986T1 (de) 2000-08-15
DK0827503T3 (da) 2000-11-20
US5994387A (en) 1999-11-30
BG102053A (en) 1998-06-30
ZA963938B (en) 1997-11-17
EP0827503B1 (en) 2000-07-26
MY132066A (en) 2007-09-28
IL118239A (en) 2000-10-31
ES2148753T3 (es) 2000-10-16
NO975210L (no) 1997-11-13
LV11992B (en) 1998-06-20
HRP960223A2 (en) 1997-10-31
LV11992A (lv) 1998-03-20
UA44320C2 (uk) 2002-02-15
CA2219631C (en) 2001-01-23
OA10747A (en) 2002-12-11
RU2161618C2 (ru) 2001-01-10
NO975210D0 (no) 1997-11-13
YU29496A (sh) 1998-12-23
BR9610858A (pt) 1999-07-13
CN1185152A (zh) 1998-06-17
PL183142B1 (pl) 2002-05-31
AU5500596A (en) 1996-11-29
AR003949A1 (es) 1998-09-30
WO1996036632A1 (en) 1996-11-21
HK1017884A1 (en) 1999-12-03
DE69609504T2 (de) 2000-12-14
CZ287939B6 (cs) 2001-03-14
CZ364897A3 (cs) 1998-11-11
PT827503E (pt) 2000-11-30
NO312068B1 (no) 2002-03-11
MX9708966A (es) 1998-03-31
AP738A (en) 1999-03-23
HUP9801761A2 (hu) 1999-05-28
IS1908B (is) 2003-12-31
NZ306448A (en) 1998-10-28
GB9510223D0 (en) 1995-07-19
TNSN96074A1 (fr) 2005-03-15
DZ2034A1 (fr) 2002-07-21
SK281782B6 (sk) 2001-07-10
SK154197A3 (en) 1999-01-11
BG63046B1 (bg) 2001-02-28
DE69609504D1 (de) 2000-08-31
IS4605A (is) 1997-10-30
HU217657B (hu) 2000-03-28
CA2219631A1 (en) 1996-11-21
CO5040221A1 (es) 2001-05-29
EP0827503A1 (en) 1998-03-11
MA23876A1 (fr) 1996-12-31
JPH10506639A (ja) 1998-06-30
PL323143A1 (en) 1998-03-16
HUP9801761A3 (en) 1999-06-28
JP3233940B2 (ja) 2001-12-04
TR199701397T1 (xx) 1998-03-21
IL118239A0 (en) 1996-09-12
CN1063175C (zh) 2001-03-14
KR19990014934A (ko) 1999-02-25
GR3034290T3 (en) 2000-12-29

Similar Documents

Publication Publication Date Title
NZ305444A (en) 4-anilino-7-alkoxy-quinazoline derivatives
IL152383A0 (en) 5-amino-3-cyano-4-ethylsulfinyl-1- phenyl-pyrazole derivatives
IL135376A0 (en) Hydroxyalkyl-phenyl derivatives
GB2306473A8 (en) Glucoxide derivatives
HU9603071D0 (en) Purin-6-one derivatives
HU9600876D0 (en) Benzonitril- and -fluoride derivatives
HU9600107D0 (en) 9-substituted-2-(2-n-alkoxy-phenyl)-purin-6-one derivatives
NZ332395A (en) Benzonthiazole derivatives
SG60005A1 (en) 1-Fluorocyclohexene-difluorophenyl derivatives
HUP9900672A3 (en) Pyrroloazepine derivatives
IL123621A0 (en) Diarylalkenylamine derivatives
HK1003299A1 (en) Benzisothiazolyl-substituted aminomethylchroman derivatives
IL117858A0 (en) 4-Indolypiperazinyl derivatives
GR3036572T3 (en) 4-amino-benzoylguanidine derivatives
HU9602324D0 (en) Piperidinyl-methyl-oxazolidinon derivatives
HK1011013A1 (en) Fluorobenzylether derivatives
GR3034245T3 (en) Substituted indole derivatives
GB9516349D0 (en) Aza-anthracyclinone derivatives
HRP960223B1 (en) Pyrrollidinyl methyl indole salt
HU9600213D0 (en) 4-mercapto-benzoyl-guanidine derivatives
EP0804205A4 (en) 4-AZA-19-NORANDROSTANDERIVATE
GB9708363D0 (en) Imidazopyridedine derivatives
SI0827503T1 (en) Pyrrolidinyl methyl indole salt
GB9523097D0 (en) Indole derivatives
SG38925A1 (en) Substituted indole derivatives

Legal Events

Date Code Title Description
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
A1OB Publication of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20030408

Year of fee payment: 8

PBON Lapse due to non-payment of renewal fee

Effective date: 20040517